topotecan has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ellis, A; Estey, E; Kantarjian, H; Keating, M; O'Brien, S; Zwelling, L | 1 |
1 trial(s) available for topotecan and Leukemia, Lymphocytic, Chronic, B-Cell
| Article | Year |
|---|---|
Topotecan in chronic lymphocytic leukemia.
Topics: Adult; Aged; Antineoplastic Agents; Camptothecin; Cross-Linking Reagents; DNA Topoisomerases, Type I; DNA-Binding Proteins; DNA, Neoplasm; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Topotecan; Treatment Outcome | 1995 |